Pollack MH, Otto MW, Roy-Byrne P, Coplan JD, Rothbaum BO, Simon NM, Gorman JM: Novel treatment approaches for refractory anxiety disorders.Depress Anxiety  2008; 25: 467— 76Roy-Byrne PP, Davidson KW, Kessler RC, Asmundson GJ, Goodwin RD, Kubzansky L, Lydiard RB, Massie MJ, Katon W, Laden SK, Stein MB: Anxiety disorders and comorbid medical illness.Gen Hosp Psychiatry  2008; 30: 208— 225Stein MB, Goin MK, Pollack MH, Roy-Byrne P, Sareen J, Simon NM, Campbell-Sills L: American Psychiatric Association Work Group on Panic Disorder. Practice guideline for the treatment of patients with panic disorder, second edition. Am J Psychiatry  (in press)Batelaan N, de Graaf R, Van Balkom A, Vollebergh W, Beekman A: Thresholds for health and thresholds for illness: panic disorder versus subthreshold panic disorder. Psychol Med  2007; 37: 247— 56Boden JM, Fergusson DM, Horwood LJ: Anxiety disorders and suicidal behaviours in adolescence and young adulthood: findings from a longitudinal study. Psychol Med  2007; 37: 431— 440Connolly SD, Bernstein GA: Practice parameter for the assessment and treatment of children and adolescents with anxiety disorders. J Am Acad Child Adolesc Psychiatry  2007; 46: 267— 283Craske MG, Farchione TJ, Allen LB, Barrios V, Stoyanova M, Rose R: Cognitive behavioral therapy for panic disorder and comorbidity: more of the same or less of more?Behav Res Ther  2007; 45: 1095— 1109Etkin A, Wager TD: Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. Am J Psychiatry  . 2007; 164: 1476— 1488Furukawa TA, Watanabe N, Churchill R: Combined psychotherapy plus antidepressants for panic disorder with or without agoraphobia. Cochrane Database Syst Rev  2007: CD004364Milrod B, Leon AC, Busch F, Rudden M, Schwalberg M, Clarkin J, Aronson A, Singer M, Turchin W, Klass ET, Graf E, Teres JJ, Shear MK: A randomized controlled clinical trial of psychoanalytic psychotherapy for panic disorder.Am J Psychiatry  2007; 164: 265— 272Pollack MH, Lepola U, Koponen H, Simon NM, Worthington JJ, Emilien G, Tzanis E, Salinas E, Whitaker T, Gao B: A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder. Depress Anxiety  2007; 24: 1— 14Siev J, Chambless DL: Specificity of treatment effects: cognitive therapy and relaxation for generalized anxiety and panic disorders. J Consult Clin Psychol  2007; 75: 513— 522Watanabe N, Churchill R, Furukawa TA: Combination of psychotherapy and benzodiazepines versus either therapy alone for panic disorder: a systematic review. BMC Psychiatry  2007; 7: 18Bystritsky A: Treatment-resistant anxiety disorders. Mol Psychiatry  2006; 11: 805— 814Carlbring P, Bohman S, Brunt S, Buhrman M, Westling BE, Ekselius L, Andersson G: Remote treatment of panic disorder: a randomized trial of internet-based cognitive behavior therapy supplemented with telephone calls. Am J Psychiatry  2006; 163: 2119— 2125Conway KP, Compton W, Stinson FS, Grant BF: Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry  2006; 67: 247— 257Furukawa TA, Watanabe N, Churchill R: Psychotherapy plus antidepressant for panic disorder with or without agoraphobia: systematic review.Br J Psychiatry  2006; 188: 305— 312Goodwin RD, Roy-Byrne P: Panic and suicidal ideation and suicide attempts: results from the National Comorbidity Survey. Depress Anxiety  2006; 23: 124— 132Heldt E, Gus Manfro G, Kipper L, Blaya C, Isolan L, Otto MW: One-year follow-up of pharmacotherapy-resistant patients with panic disorder treated with cognitive-behavior therapy: outcome and predictors of remission. Behav Res Ther  2006; 44: 657— 665Kessler RC, Chiu WT, Jin R, Ruscio AM, Shear K, Walters E: The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication. Arch Gen Psychiatry  2006; 63: 415— 424Katon WJ: Clinical practice: panic disorder. N Engl J Med  2006; 354: 2360— 2367Paulus MP, Stein, MB: An insular view of anxiety. Biol Psychiatry  2006; 60: 383— 387Ross, LE, McLean LM: Anxiety disorders during pregnancy and the postpartum period: a systematic review. J Clin Psychiatry  2006; 67: 1285— 1298Roy-Byrne P, Craske M, Stein M: Panic disorder. Lancet  2006; 368: 1023— 1032Sareen J, Chartier M, Paulus MP, Stein MB: Illicit drug use and anxiety disorders: findings from two community surveys. Psychiatry Res  2006; 142: 11— 17Schraufnagel TJ, Wagner AW, Miranda J, Roy-Byrne PP: Treating minority patients with depression and anxiety: what does the evidence tell us.Gen Hosp Psychiatry  2006; 28: 27— 36Westra H, Dozois D: Preparing clients for cognitive behavior therapy: a randomized pilot study of motivational interviewing for anxiety. Cogn Ther Res  2006; 30: 481— 498Bruce SE, Yonkers KA, Otto MW, Eisen JL, Weisberg RB, Pagano M, Shea MT, Keller MB: Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12-year prospective study.Am J Psychiatry  2005; 162: 1179— 1187Carlbring P, Nilsson-Ihrfelt E, Waara J, Kollenstam C, Buhrman M, Kaldo V, Söderberg M, Ekselius L, Andersson G: Treatment of panic disorder: live therapy vs. self-help via the Internet. Behav Res Ther  2005; 43: 1321— 1333Flint A: Anxiety and its disorders in late life: moving the field forward. Am J Geriatric Psychiatry  2005; 13: 3— 6Hettema JM, Prescott CA, Meyers JM, Neale MC, Kendler KS: The structure of genetic and environmental risk factors for anxiety disorders in men and women. Arch Gen Psychiatry  2005; 62: 182— 189Mitte K: A meta-analysis of the efficacy of psycho- and pharmacotherapy in panic disorder with and without agoraphobia. J Affect Disord  2005; 88: 27— 45Roy-Byrne PP, Craske MG, Stein MB, Sullivan G, Bystritsky A, Katon W, Golinelli D, Sherbourne CD: A randomized effectiveness trial of cognitive-behavioral therapy and medication for primary care panic disorder. Arch Gen Psychiatry  2005; 62: 290— 298Smoller JW, Yamaki LH, Fagerness JA, Biederman J, Racette S, Laird NM, Kagan J, Snidman N, Faraone SV, Hirshfeld-Becker D, Tsuang MT, Slaugenhaupt SA, Rosenbaum JF, Sklar PB: The corticotropin-releasing hormone gene and behavioral inhibition in children at risk for panic disorder. Biol Psychiatry  2005; 57: 1485— 1492Biederman J, Petty C, Faraone SV, Hirshfeld-Becker D, Pollack MH, Henin A, Gilbert J, Rosenbaum JF: Moderating effects of major depression on patterns of comorbidity in patients with panic disorder. Psychiatry Res  2004; 14: 126, 143— 149Deacon BJ, Abramowitz JS: Cognitive and behavioral treatments for anxiety disorders: a review of meta-analytic findings.J Clin Psychol  2004; 160: 429— 441National Institute for Clinical Excellence: Anxiety: management of anxiety (panic disorder, with or without agoraphobia, and generalised anxiety disorder) in adults in primary, secondary and community care. 2004. http://www.nice.org.uk/CG022quickrefguideSheikh JI, Swales PJ, Carlson EB, Lindley SE: Aging and panic disorder: phenomenology, comorbidity, and risk factors. Am J Geriatr Psychiatry  2004; 12: 102— 109Fleet RP, Lavoie KL, Martel JP, Dupuis G, Marchand A, Beitman BD: Two-year follow-up status of emergency department patients with chest pain: was it panic disorder? CJEM  2003; 5: 247— 254Lewis-Fernandez R, Guarnaccia PJ, Martinez IE, Salman E, Schmidt A, Liebowitz M: Comparative phenomenology of ataques de nervios, panic attacks, and panic disorder. Cult Med Psychiatry  2002; 26: 199— 223Goddard AW, Brouette T, Almai A, Jetty P, Woods SW, Charney D: Early coadministration of clonazepam with sertraline for panic disorder. Arch Gen Psychiatry  2001; 58: 681— 686Katzelnick DJ, Kobak KA, DeLeire T, Henk HJ, Greist JH, Davidson JR, Schneier FR, Stein MB, Helstad CP: Impact of generalized social anxiety disorder in managed care. Am J Psychiatry  2001; 158: 1999— 2007Fleet RP, Marchand A, Dupuis G, Kaczorowski J, Beitman BD: Comparing emergency department and psychiatric setting patients with panic disorder. Psychosomatics  1998; 39: 512— 518Shear MK, Brown TA, Barlow DH, Money R, Sholomskas DE, Woods SW, Gorman JM, Papp LA: Multicenter collaborative Panic Disorder Severity Scale. Am J Psychiatry  1997; 154: 1571— 1575Nagy LM, Krystal JH, Woods SW, Charney DS: Clinical and medication outcome after short-term alprazolam and behavioral group treatment in panic disorder. 2.5 year naturalistic follow-up study. Arch Gen Psychiatry  1989; 46: 993— 999Klein DF: Delineation of two drug-responsive anxiety syndromes. Psychopharmacologia  1964; 5: 397— 408Klein DF, Fink M: Psychiatric reaction patterns to imipramine.Am J Psychiatry  1962; 119: 432— 438

Mörtberg E, Clark DM, Sundin O, Aberg Wistedt A. Intensive group cognitive treatment and individual cognitive therapy vs. treatment as usual in social phobia: a randomized controlled trial. Acta Psychiatr Scand  2007; 115: 142— 154Sareen J, Campbell DW, Leslie WD, Malisza KL, Stein MB, Paulus MP, Kravetsky LB, Kjernisted KD, Walker JR, Reiss JP: Striatal function in generalized social phobia: a functional magnetic resonance imaging study. Biol Psychiatry  2007; 61: 396— 404Foa EB: Social anxiety disorder treatments: psychosocial therapies. J Clin Psychiatry  2006; 67( suppl 12): 27— 30Hofmann SG, Meuret AE, Smits JA, Simon NM, Pollack MH, Eisenmenger K, Shiekh M, Otto MW: Augmentation of exposure therapy with D-cycloserine for social anxiety disorder. Arch Gen Psychiatry  2006; 63: 298— 304Matthew SJ, Ho S: Etiology and neurobiology of social anxiety disorder. J Clin Psychiatry  2006; 67( suppl 12): 9— 13Phan KL, Fitzgerald DA, Nathan PJ, Tancer ME: Association between amygdala hyperactivity to harsh faces and severity of social anxiety in generalized social phobia. Biol Psychiatry  2006; 59: 424— 429Stein MB: An epidemiologic perspective on social anxiety disorder. J Clin Psychiatry  2006; 67( suppl 12): 3— 8Liebowitz MR, Mangano RM, Bradwejn J, Asnis G, SAD Study Group: A randomized controlled trial of venlafaxine extended release in generalized social anxiety disorder. J Clin Psychiatry  2005; 66: 238— 247Mancini C, Van Ameringen M, Bennett M, Patterson B, Watson C: Emerging treatments for child and adolescent social phobia: a review. J Child Adolesc Psychopharmacol  2005; 15: 589— 607Bögels SM, Mansell W: Attention processes in the maintenance and treatment of social phobia: hypervigilance, avoidance and self-focused attention. Clin Psychol Rev  . 2004; 24: 827— 856Van Ameringen M, Mancini C, Pipe B, Oakman J, Bennett M: An open trial of topiramate in the treatment of generalized social phobia. J Clin Psychiatry  2004; 65: 1674— 1678Heimberg RG: Cognitive-behavioral therapy for social anxiety disorder: current status and future directions. Biol Psychiatry  2002; 51: 101— 108Stein MB, Kean YM: Disability and quality of life in social phobia: epidemiologic findings. Am J Psychiatry  2000; 157: 1606— 1613Liebowitz MR, Heimberg RG, Schneier FR, Hope DA, Davies S, Holt CS, Goetz D, Juster HR, Lin SH, Bruch MA, Marshall RD, Klein DF: Cognitive-behavioral group therapy versus phenelzine in social phobia: long-term outcome. Depress Anxiety  1999; 10: 89— 98Kessler RC, Berglund P: Social phobia subtypes in the National Comorbidity Survey. Am J Psychiatry  1998; 155: 613— 619Heimberg RG, Liebowitz MR, Hope DA, Schneier FR, Holt CS, Welkowitz LA, Juster HR, Campeas R, Bruch MA, Cloitre M, Fallon B, Klein DF: Cognitive behavioral group therapy vs phenelzine therapy for social phobia: 12-week outcome. Arch Gen Psychiatry  1998; 55: 1133— 1141Liebowitz MR, Schneier F, Campeas R, Hollander E, Hatterer J, Fyer A, Gorman J, Papp L, Davies S, Gully R: Phenelzine vs atenolol in social phobia; a placebo-controlled comparison. Arch Gen Psychiatry  1992; 49: 290— 300